UnitedHealth Group (NYSE: UNH) Earnings Q1 2011





View UnitedHealth Group's (NYSE: UNH) Q1 Earnings Report 


Highlights:

  • Revenues totaled $25.4 billion, increasing nearly 10 percent year-over-year
  • Earnings from operations increased 10 pecent, to $2.2 billion, net earnings were up 13 percent, to $1.35 billion ($1.22 per share, up 18 percent from Q1 2010)
  • The medical care ratio for Q1 2011 was 81.4 percent, increasing 10 basis points year-over-year. This will likely continue to rise, the compay projects.
  • Optum businesses boosted revenues by 20 percent year-over-year, largely due to expanded clinical services and strong consumer growth in population health management products, including behavioral health management, wellness and health coaching services
  • UnitedHealthcare businesses grew by more than 1.2 million people in Q1 2011
  • The full-year financial outlook expects 2011 revenues of $101 billion, net earnings in the range of $3.95 to $4.05 per share and cash flows from operations between $5.8 billion and $6.2 billion

Notable quote: "In 2011, we expect consumer usage of the health system to increase, resuming its upward growth pattern from the recent moderation in utilization growth. We will work to manage medical cost trends through affordable network relationships, pay-for-performance reimbursement programs for care providers, and targeted clinical initiatives around improving quality and affordability. However, an increase in utilization will likely result in increased medical costs and an increase in our medical care ratio."

For more information:
- Read the company's 10-Q report filed with the SEC
- Read this press release
- Check out UnitedHealth Group's current earnings estimates from CNN Money
- See how UNH is performing right now
- UnitedHealth Group's website: www.unitedhealthgroup.com

Suggested Articles

Blues plans have reportedly agreed to a $2.7 billion antitrust settlement.

Premera Blue Cross will pay $6.9 million to HHS over a data breach six years ago that exposed 10 million people's health information.

HHS and the FDA finalized a rule that enables states to seek approval to re-import certain drugs from Canada for a cheaper price.